<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Preclinical and clinical studies have demonstrated that a free radical scavenger <z:chebi fb="0" ids="31530">edaravone</z:chebi> has neuroprotective effects on <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> but the underlying mechanism is not fully understood </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this research is to explore the effect of <z:chebi fb="0" ids="31530">edaravone</z:chebi> on the apoptotic process involving the Fas/FasL signaling pathway </plain></SENT>
<SENT sid="2" pm="."><plain>Transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats was induced for 2 hours by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>After reperfusion rats were treated i.v. with either <z:chebi fb="0" ids="31530">edaravone</z:chebi> or physiological saline </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein (FADD), <z:hpo ids='HP_0011420'>death</z:hpo>-associated protein (Daxx) and caspase-8 was examined by immunohistochemistry </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels for FADD and Daxx by reverse-transcriptase PCR (RT-PCR) and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was assessed by terminal deoxynucleotidyltransferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi>-<z:chebi fb="1" ids="15956">biotin</z:chebi> nick end labeling (TUNEL) </plain></SENT>
<SENT sid="6" pm="."><plain>Neurological scores and infarction volumes were also evaluated </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="31530">Edaravone</z:chebi> significantly improved the neurological outcome (p&lt;0.05) and reduced the total <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes (p&lt;0.05), compared with saline control </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, <z:chebi fb="0" ids="31530">edaravone</z:chebi>-treatment significantly reduced the number of TUNEL-positive cells (p&lt;0.01), reduced expression levels of FADD, Daxx and caspase-8 immunoreactivity (p &lt;0.05 approximately 0.01), and decreased <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of FADD and Daxx (p&lt;0.05 approximately 0.01) within the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> area </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that <z:chebi fb="0" ids="31530">edaravone</z:chebi> may protect ischemic neurons from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via suppressing the gene expression of the Fas/FasL signaling pathway </plain></SENT>
</text></document>